Active substances
Sulfametrole + Trimethoprim
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| LIDAPRIM FORTE TAB | 160, 800 mg | Tablet · Oral use | 10 Blister | SAR 38.10 | NCE · Prescription | Takeda Manufacturing Austria AG | Withdrawn by MAH · Not Marketed |
| LIDAPRIM ORAL SUSP.FOR CHILD | 4, 20 mg/ml | Effervescent granules for oral suspension · Oral use | 1 Bottle | SAR 30.95 | NCE · Prescription | Takeda Manufacturing Austria AG | Withdrawn by MAH · Not Marketed |
| LIDAPRIM PED. TAB. 20 TABS. | 20, 100 mg | Tablet · Oral use | 20 Blister | SAR 18.35 | NCE · Prescription | Takeda Manufacturing Austria AG | Withdrawn by MAH · Not Marketed |
| LIDAPRIM TAB | 80, 400 mg | Tablet · Oral use | 20 Blister | SAR 22.00 | NCE · Prescription | Takeda Manufacturing Austria AG | Withdrawn by MAH · Not Marketed |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.